SEARCH

SEARCH BY CITATION

References

  • Amuron B, Namara G, Birungi J et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health9, 290.
  • Bassett IV, Wang B, Chetty S et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. Journal of Acquired Immune Deficiency Syndromes51, 135139.
  • Bassett IV, Regan S, Chetty S et al. (2010) Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS24 (Suppl. 1), S37S44.
  • Boulle A, Bock P, Osler M et al. (2008) Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization86, 678687.
  • Brinkhof MW, Dabis F, Myer L et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization86, 559567.
  • Brinkhof MW, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One4, e5790.
  • Chi BH, Cantrell RA, Mwango A et al. (2010) An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. American Journal of Epidemiology171, 924931.
  • Etienne M, Burrows L, Osotimehin B et al. (2010) Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries. Tropical Medicine and International Health15 (Suppl. 1), 7681.
  • Fenner L, Brinkhof MW, Keiser O et al. (2010) Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. Journal of Acquired Immune Deficiency Syndromes54, 524532.
  • Fox MP & Rosen S (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa 2007–2009: systematic review. Tropical Medicine and International Health15 (Suppl. 1), 115.
  • Grant AD, Charalambous S, Fielding KL et al. (2005) Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA293, 27192725.
  • Karcher H, Omondi A, Odera J, Kunz A & Harms G (2007) Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Tropical Medicine and International Health12, 687694.
  • Krebs DW, Chi BH, Mulenga Y et al. (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care20, 311317.
  • Larson BA, Brennan A, Mcnamara L et al. (2010) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Tropical Medicine and International Health15 (Suppl. 1), 4347.
  • Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS22, 18971908.
  • Lessells RJ, Mutevedzi PC, Cooke GS & Newell ML (2011) Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. Journal of Acquired Immune Deficiency Syndromes56, e79e86.
  • Losina E, Bassett IV, Giddy J et al. (2010) The “ART” of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One5, e9538.
  • Maskew M, Macphail P, Menezes C & Rubel D (2007) Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. South African Medical Journal97, 853857.
  • McGuire M, Munyenyembe T, Szumilin E et al. (2010) Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Tropical Medicine and International Health15 (Suppl. 1), 5562.
  • Merten S, Kenter E, Mckenzie O, Musheke M, Ntalasha H & Martin-Hilber A (2010) Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Tropical Medicine and International Health15 (Suppl. 1), 1633.
  • Ochieng-Ooko V, Ochieng D, Sidle JE et al. (2010) Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bulletin of the World Health Organization88, 681688.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med4, e298.
  • Russell EC, Charalambous S, Pemba L, Churchyard GJ, Grant AD & Fielding K (2010) Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study. BMC Public Health10, 433.
  • Tassie JM, Baijal P, Vitoria MA, Alisalad A, Crowley SP & Souteyrand Y (2010) Trends in retention on antiretroviral therapy in national programs in low-income and middle-income Countries. Journal of Acquired Immune Deficiency Syndromes54, 437441.
  • Toure S, Kouadio B, Seyler C et al. (2008) Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS22, 873882.
  • UNAIDS2010. UNAIDS Outlook Report. Geneva, Switzerland.
  • Walson JL, Otieno PA, Mbuchi M et al. (2008) Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS22, 16011609.
  • WHO2006. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. WHO, Geneva.
  • Yiannoutsos CT, An MW, Frangakis CE et al. (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One3, e3843.
  • Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bulletin of the World Health Organization85, 550554.